
Wei Yong Team from Eye Hospital of Wenzhou Medical University Pioneers Laser-Free Surgical Model for BRVO with Vitreous Hemorrhage
The world's first prospective randomized controlled trial showed that intraoperative anti-VEGF drug treatment can replace laser as a superior option after vitrectomy for BRVO combined with vitreous hemorrhage, refreshing understanding of rebleeding mechanisms.
The Affiliated Eye Hospital of Wenzhou Medical University